Connect with us

Industry

Major UK white label CBD plant taken over by Fen Group

Published

on

A spokesperson for Fen Group said further buyouts are in the pipeline

White Label 360, a CBD manufacturing operation based in the north of England, has been acquired by consumer healthcare firm, Fen Group.

A spokesperson for Fen Group said further buyouts are in the pipeline as they ‘seek to become the dominant player in the UK CBD market’.

Incorporated in 2018, the West Yorkshire-based company will take control of White Label 360’s flagship brand, ‘CBDeaze’.

The company is now awaiting validation from the Food Standards Agency (FSA) as per the new novel foods legislation.

In a statement, Fen Group said the acquisition could open up ‘potential distribution channels’ in Germany and South Africa.

White Label, which has a plant in Barnsley and has been trading since 2015, has 40 white label contacts according to the company’s website.

Its CEO, Colin O’Donnell, said he supported Fen Group’s efforts to ‘bring structure into such a fragmented CBD market in the UK’.

“I am looking forward to working with Fen Group as they endeavour to bring structure into such a fragmented CBD market in the UK,” he commented.

Tom Fennell, CEO of Fen Group said: “This acquisition allows Fen Group to rapidly increase our revenues, whilst keeping our core value proposition consistent.

“We are very excited to build on the foundational work that Colin has put in.”

Trending

Cannabis Health is a journalist-led news site. Any views expressed by interviewees or commentators do not reflect our own. All content on this site is intended for educational purposes, please seek professional medical advice if you are concerned about any of the issues raised.

Copyright © 2024 PP Intelligence Ltd.